Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 3,308,700 | 3,114,300 | 2,743,300 | 2,539,300 | 2,225,100 |
| Cost of Goods | 2,543,700 | 2,368,700 | 2,095,800 | 1,964,400 | 1,733,700 |
| Gross Profit | 765,000 | 745,600 | 647,500 | 574,900 | 491,400 |
| Operating Expenses | 376,200 | 397,500 | 320,300 | 230,100 | 189,900 |
| Operating Income | 389,500 | 348,800 | 328,000 | 345,200 | 302,200 |
| Interest Expense | 295,500 | 221,200 | 207,200 | 247,400 | 232,300 |
| Other Income | 22,900 | 19,500 | 14,200 | 12,500 | 11,300 |
| Pre-tax Income | 116,900 | 147,100 | 135,000 | 110,300 | 81,200 |
| Income Tax | 18,000 | 134,600 | -300 | 23,300 | 10,500 |
| Net Income Continuous | 98,900 | 12,500 | 135,300 | 87,000 | 70,700 |
| Minority Interests | 176,800 | 180,600 | 147,200 | 141,600 | 141,600 |
| Net Income | $-77,900 | $-168,100 | $-11,900 | $-54,600 | $-70,900 |
| EPS Basic Total Ops | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
| EPS Basic Continuous Ops | 0.78 | 0.10 | 1.08 | 0.95 | 0.98 |
| EPS Diluted Total Ops | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
| EPS Diluted Continuous Ops | 0.78 | 0.10 | 1.08 | 0.95 | 0.98 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.67 | 0.86 | -0.04 | -0.25 |
| EBITDA(a) | $588,400 | $520,900 | $460,300 | $472,500 | $412,300 |